BUCLIZINE HCL

Buclizine hydrochloride is an antihistamine with antiemetic and appetite‑stimulating effects. Side effects include drowsiness, dry mouth, and dizziness.

SKU: 429eaa45fa6e Category: Tag:

Product Description


Mechanism of action

Buclizine hydrochloride is a piperazine‑derived first‑generation antihistamine that blocks H₁ receptors and exhibits significant anticholinergic and antiemetic activity. It reduces vestibular stimulation and suppresses nausea pathways.

Benefits and advantages

Used in motion‑sickness models, antihistamine SAR profiling, vestibular‑system research, anticholinergic‑burden analysis and antiemetic‑mechanism studies.

Side effects and risks

Risks include sedation, dry mouth, constipation, blurred vision, cognitive impairment and anticholinergic toxicity at high doses. Handle with CNS‑active antihistamine precautions.

Datasheet


Molecular Formula

C28H35Cl3N2

Molecular Weight

505.9 g/mol

CAS Number

129-74-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

2.46e-04 g/L

Purity

Purity information is available upon request (COA).

Synonym

Buclizine dihydrochloride; 129-74-8; Buclizine hydrochloride; Longifene; Buclizine HCl

IUPAC/Chemical Name

1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride

InChl Key

SDBHDSZKNVDKNU-UHFFFAOYSA-N

InChl Code

InChI=1S/C28H33ClN2.2ClH/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24;;/h4-16,27H,17-21H2,1-3H3;2*1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/65463;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download